Feature Channels:

Blood Disorders

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Red Blood Cell, Blood, Transfusions, Guidelines, Aaron Tobian, Tobain, Jeffrey Carson, Carson

Expert Panel Issues Updated Guidelines for Red Blood Cell Storage Time and Transfusion Use

Blood_Transfusion_Bags_iStock_11963764.jpg

For most stable hospitalized patients, transfusions of red blood cells stored for any time point within their licensed dating period — so-called standard issue — are as safe as transfusions with blood stored 10 days or less, or “fresh,” according to updated clinical guidelines issued by an expert panel convened by a national organization that has long set standards for blood banking and transfusion practices.

Medicine

Channels:

Blood Transfusion, blood transfusion threshold, aabb, hemogloblin, Rutgers, JAMA, Robert Wood Johnson

New Guidelines for Life-Saving Blood Transfusions Based on Rutgers Research

Carson_Jeffrey_JE2016.jpg

Most patients who need blood transfusions – including those who are critically ill – can be given blood when their hemoglobin drops to a lower level than practiced traditionally, according to AABB, a national association of blood banks that based its recommendation on research led by Rutgers University.

Medicine

Channels:

Light the Night, L.A. Live, Blood Cancers, Lymphoma, Leukemia, LLS

UCLA Health Prepares to ‘Light the Night’ at Evening Walk to Benefit Blood-Cancer Research, Patients

Seven-year-old Rey Ahumada should be jumping and playing outside like most other children his age. Instead, he’s fighting leukemia and “stuck in a bubble,” says his mom, an admissions clerk at UCLA Medical Center, Santa Monica. “That word, ‘cancer,’” she adds. “We need to put an end to it.” With that as a goal, UCLA Health is presenting sponsor of the Leukemia & Lymphoma Society’s Oct. 22 “Light the Night Walk” in Los Angeles. Jassmine will be carrying a red lantern in support of Rey and other patients with blood cancers who are hoping for a cure. Individuals who wish to commemorate a loved one lost to cancer will carry yellow lanterns, while cancer survivors will carry white, signifying the power of research.

Medicine

Channels:

Upstate Medical University Research Provides Insight Into Cause of Rare Blood Cancer

In a laboratory study, Upstate Medical University researcher Golam Mohi, Ph.D., his graduate student Yue Yang, and colleagues, have found that the loss of gene EZH2 promotes the development of Myelofibrosis (MF) in mice. The findings create a new pathway for study into the cause of MF and provide new therapeutic targets to block the progression of this rare form of blood cancer.

Business

Channels:

Breast Cancer, Cancer

Seattle Cancer Care Alliance Opens Prostate Cancer Genetics Specialty Clinic

Cheng-Heather.jpg

SEATTLE – (Sept. 20, 2016) – Seattle Cancer Care Alliance (SCCA) has opened a new Prostate Cancer Genetics Clinic at their South Lake Union campus in Seattle. The specialty clinic will serve patients with prostate cancer that has spread beyond the prostate (metastatic) and/or who have a family history of the disease or a family history of breast cancer, ovarian cancer, pancreatic cancer, lymphoma or leukemia. These men are more likely to have an inherited and more aggressive form of prostate cancer. Knowing a patient has a particular genetic mutation helps doctors choose the best treatment plan and can open doors for innovative clinical trials.

Medicine

Channels:

TKIs, CML, Medicare Part D

High Up-Front Costs Could Delay Access to Life-Saving Blood Cancer Drugs for Medicare Patients

Dusetzinapreferred.jpg

In the study published in the Journal of Clinical Oncology, UNC Lineberger researchers report that nearly a third of a group of patients with chronic myeloid leukemia, and who have federally-funded Medicare health insurance, did not start treatment within six months of diagnosis with any of three targeted drugs that have led to dramatic improvements in survival for the disease.

Medicine

Channels:

Sepsis, sepsis early warning and response tool , sepsis prevention

Pennsylvania Leaders and Pinnacle Health Call on Citizens to Join New Campaign To "Knock Out Sepsis" and Save Lives

04691-sepsis-183MAYatpodium.jpg

Knock Out Sepsis" campaign launched from the Harrisburg State Capitol Rotunda for Sepsis Awareness Month.

Medicine

Channels:

Sandra Rotman Centre for Global Health, University Of Toronto, University Health Network, Science Translational Medicine , Toronto General Research Institute , TGRI, UHN, UFT and UHN, UHN collaborative work, UHN research, Malaria, antimalarial drugs, Antimalarial, Global Health, Cerebral Malaria, children illness, children disease, children with malaria, ne

Treating Malaria by Stabilizing Leaky Blood Vessels

Boosting a protective protein to stabilize blood vessels that are weakened by malaria showed improved survival, beyond that of antimalarial drugs alone in pre-clinical research. Toronto General Research Institute (TGRI) and the Sandra Rotman Centre for Global Health, University of Toronto and University Health Network (UHN) researchers describe in Science Translational Medicine how their approach bolsters the body’s own capabilities to protect itself against cerebral malaria, rather than solely targeting the malaria parasites in the blood.

Medicine

Channels:

Artificial Blood Vessels Developed in the Lab Can Grow with the Recipient

tranquillo_implantphoto.jpg

In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient. If confirmed in humans, these new vessel grafts would prevent the need for repeated surgeries in some children with congenital heart defects.

Medicine

Channels:

Earlier Treatment with Surgery to Remove Blood Clot Linked with Less Disability Following Stroke

In an analysis that included nearly 1,300 patients with large-vessel ischemic stroke, earlier treatment with endovascular thrombectomy (intra-arterial use of a micro-catheter or other device to remove a blood clot) plus medical therapy (use of a clot dissolving agent) compared with medical therapy alone was associated with less disability at 3 months, according to a study appearing in the September 27 issue of JAMA.

Medicine

Channels:

NCCN, National Comprehensive Cancer Network, nccn clinical practice guidelines in oncology, nccn guidelines, Myeloproliferative Neoplasms, Cancer, Oncology, Hematology, Mayo Clinic, Cancer Treatment, Blood Cancer

NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms

NCCNGuidelines_MPN_12017.jpg

New NCCN Guidelines for Myeloproliferative Neoplasms focus on the treatment of Myelofibrosis, a rare bone marrow cancer; the new recommendations are the most comprehensive treatment guidance available to U.S. clinicians today.

Medicine

Science

Channels:

American Thyroid Association's 2016 Van Meter Award Lecture Delivered by Robin P. Peeters, MD, PhD

The American Thyroid Association (ATA) is proud to announce that the 2016 Van Meter Award recipient is Robin P. Peeters, MD, PhD, Professor of Internal Medicine and Head of the Thyroid Laboratory at Erasmus Medical Center, Rotterdam, The Netherlands, and Director of the Rotterdam Thyroid Center, which he founded in 2011. Dr. Peeters presents the Van Meter Award Lecture, titled “How to define optimal thyroid function?” at the ATA's 86th Annual Meeting, on Saturday, September 24, 2016, in Denver, Colorado.

Science

Channels:

Thyroid Disease

American Thyroid Association Announces Recipient of the 2016 Distinguished Service Award

The American Thyroid Association (ATA) has announced that the recipient of the 2016 Distinguished Service Award is Gregory A. Brent, M.D., Professor of Medicine and Physiology, David Geffen School of Medicine, University of California, Los Angeles, and Chair, Department of Medicine at VA Greater Los Angeles Healthcare System. The ATA will present the award to Dr. Brent at its 86th Annual Meeting, September 21-25, 2016, in Denver, Colorado.

Science

Channels:

Thyroid Disease

Latest Advances in Clinical Thyroid Research Presented at American Thyroid Association Annual Meeting

Leading clinicians and scientists from around the globe came together to share and discuss the most recent research data to help improve the care of patients with thyroid disease at the upcoming 86th Annual Meeting of the American Thyroid Association (ATA), September 21-25, 2016, in Denver, Colorado. Among the many oral and poster presentations delivered at the ATA meeting that highlighted advances in clinical research are a select few described below.

Science

Channels:

Thyroid Disease

American Thyroid Association Announces Recipient of the 2016 Lewis E. Braverman Lectureship Award

The American Thyroid Association (ATA) has announced that the recipient of the 2016 Lewis E. Braverman Lectureship Award is P. Reed Larsen, M.D., a member of the Thyroid Section, Division of Endocrinology, Diabetes and Hypertension, at Brigham and Women's Hospital, and Professor of Medicine at Harvard Medical School, Boston, MA. Dr. Larsen will deliver the Lewis E. Braverman Lecture, entitled "Deiodinases, Cofactors & the Low T3 Syndrome," at the ATA's 86th Annual Meeting, September 21-25, 2016, in Denver, Colorado. The Lewis E. Braverman Lectureship Award recognizes an individual who has demonstrated excellence and passion for mentoring fellows, students and junior faculty, has a long history of productive thyroid research, and is devoted to the ATA. The award is endowed by contributions to honor Dr. Lewis E. Braverman.

Medicine

Channels:

thyroidology, Thyroid Disease

Plenary and Award Lectures, Latest Research on Thyroid Disease and Cancer, Hot Topic Debates, and Oral and Poster Presentations Featured at American Thyroid Association Annual Meeting

Key opinion leaders, thyroid specialists, clinical and basic researchers, and young trainees will come together for five exciting and information-filled days of symposia, scientific presentations, and discussions on the latest advances in thyroidology and clinical management of thyroid disease as members of the American Thyroid Association (ATA) gather in Denver, Colorado for the 86th Annual Meeting of the ATA. With nearly 1300 registered attendees to date, and 395 regular abstracts and 77 late breaking abstracts submitted, the meeting promises to be an outstanding educational and networking opportunity.

Medicine

Channels:

Cancer, Hematology, Clinical Trials, Blood Cancer

At Bat Against Rare Blood Cancers

wieduwilt_symposium.jpg

University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients.

Medicine

Channels:

Size Is Everything When It Comes to High Blood Pressure

Hypertensionarticle.jpg

The size of a grain of rice, the carotid body, located between two major arteries that feed the brain with blood, has been found to control your blood pressure.

Medicine

Channels:

Heparin, Clots, Blood Clots, Aspirin, Trauma, Death, Fracture

Largest-Ever Study to Compare Medications to Prevent Life-Threatening Clots in Orthopaedic Trauma Patients

Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. To reduce this risk, doctors have prescribed low molecular weight heparin. But some researchers argue that aspirin may be just as effective. A comprehensive new study will try to resolve this question.

Medicine

Channels:

Hypertension, Sprint, Systolic Blood Pressure Intervention Trial, High Blood Pressure

Lowering Systolic Blood Pressure Would Save More Than 100,000 Lives Per Year, Study Finds

Intensive treatment to lower systolic (top number) blood pressure to below 120 would save more than 100,000 lives per year in the United States. Two thirds of the lives saved would be men and two thirds would be aged 75 or older.







Chat now!